Literature DB >> 17904901

Monitoring of human cytomegalovirus infection in immunosuppressed patients using real-time PCR on whole blood.

C Deback1, A M Fillet, N Dhedin, B Barrou, S Varnous, F Najioullah, F Bricaire, H Agut.   

Abstract

BACKGROUND: Quantitative monitoring of human cytomegalovirus (HCMV) is currently used in the follow-up of immunosuppressed patients.
OBJECTIVE: To investigate whether real-time PCR quantification (QPCR) of HCMV DNA could replace pp65 antigenemia. STUDY
DESIGN: We compared HCMV QPCR on whole blood (WB) and on plasma with a pp65-antigenemia assay on 192 samples. Afterwards, we tested 1310 samples from 308 immunosuppressed patients both by antigenemia assay and QPCR on WB.
RESULTS: The first study comparison showed that QPCR results on WB and plasma were significantly correlated with antigenemia. QPCR on WB was more sensitive than QPCR on plasma or antigenemia, detecting 31 and 49 additional positive samples, respectively. During the second comparison, QPCR on WB and antigenemia were again correlated (r=0.70; p<0.0001), but QPCR detected 244 additional positive samples. HCMV DNA was detected earlier than pp65 antigen (median difference: 14 days; range: 7-30). One, 5, 10, 50 and 100 pp65-positive cells/200,000 leukocytes corresponded to 439, 1531, 2623, 9150 and 15,671 HCMV DNA copies/mL of WB, respectively, but this equivalence differed according to the sub-group of patients considered.
CONCLUSION: QPCR on WB is the most sensitive method for the monitoring of HCMV infection in immunosuppressed patients.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17904901     DOI: 10.1016/j.jcv.2007.08.014

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  5 in total

1.  Rapid quantitation of cytomegalovirus DNA in whole blood by a new molecular assay based on automated sample preparation and real-time PCR.

Authors:  Reinhard B Raggam; Michael Bozic; Helmut J F Salzer; Sandra Hammerschmidt; Cordula Homberg; Katharina Ruzicka; Harald H Kessler
Journal:  Med Microbiol Immunol       Date:  2010-06-18       Impact factor: 3.402

2.  Comparative evaluation of a commercially available automated system for extraction of viral DNA from whole blood: application to monitoring of epstein-barr virus and cytomegalovirus load.

Authors:  Sylvie Pillet; Thomas Bourlet; Bruno Pozzetto
Journal:  J Clin Microbiol       Date:  2009-08-26       Impact factor: 5.948

3.  Surveillance of active human cytomegalovirus infection in hematopoietic stem cell transplantation (HLA sibling identical donor): search for optimal cutoff value by real-time PCR.

Authors:  Renata M B Peres; Cláudia R C Costa; Paula D Andrade; Sandra H A Bonon; Dulcinéia M Albuquerque; Cristiane de Oliveira; Afonso C Vigorito; Francisco J P Aranha; Cármino A de Souza; Sandra C B Costa
Journal:  BMC Infect Dis       Date:  2010-06-01       Impact factor: 3.090

4.  Expansion of human cytomegalovirus (HCMV) immediate-early 1-specific CD8+ T cells and control of HCMV replication after allogeneic stem cell transplantation.

Authors:  Karim Sacre; Stéphanie Nguyen; Claire Deback; Guislaine Carcelain; Jean-Paul Vernant; Véronique Leblond; Brigitte Autran; Nathalie Dhedin
Journal:  J Virol       Date:  2008-08-06       Impact factor: 5.103

5.  Detection of human cytomegalovirus DNA in various blood components after liver transplantation.

Authors:  X Y Chen; P F Hou; J Bi; C M Ying
Journal:  Braz J Med Biol Res       Date:  2014-04-08       Impact factor: 2.590

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.